Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

National Institutes of Health

This source publishes only summary fields for this notice. Open the official notice for the full scope of work.

Deadline

15 Oct 2027(409 days left)

Published

26 Nov 2024(21 months ago)

Contract value

Not published

Location

United States

Reference

357430

First seen

5 hours ago